Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Urology. 2018 Mar 28;115:133–138. doi: 10.1016/j.urology.2018.01.048

Table 2.

Bivariate and multivariable analyses of patient-level characteristics associated with urologists’ recommendations to forgo definitive treatment among men with limited life expectancies

Urologist treatment recommended forgoing definitive
No (N, %) Yes (N, %) P-value Adjusted Odds Ratio (95% Confidence Interval)*
350 (48.8%) 318 (44.3%)
NCCN risk
High 146 (61.3) 92 (38.7) <0.001 Ref
Intermediate 190 (54.9) 156 (45.1) 1.37 (0.95–1.96)
Low 63 (35.4) 115 (64.6) 3.41 (2.17–5.37)
Race
Non-Hispanic White 345 (52.1) 317 (47.9) 0.68 Ref
Non-Hispanic Black 83 (50.3) 82 (49.7) 0.96 (0.63–1.46)
Education
High school or less 156 (47.0) 176 (53.0) 0.05 Ref
Some college 81 (46.6) 93 (53.5) 0.98 (0.65–1.48)
College graduate 54 (59.3) 37 (40.7) 0.67 (0.40–1.14)
More than college 107 (56.0) 84 (44.0) 0.68 (0.44–1.04)
Insurance
Private 141 (50.9) 136 (49.1) 0.97 Ref
Medicare 266 (50.5) 261 (49.5) 1.27 (0.90–1.78)
Other 22 (52.4) 20 (47.6) 0.93 (0.45–1.93)
Employment
Employed 69 (46.3) 80 (53.7) 0.18 Ref
Retired 267 (52.6) 241 (47.4) 0.69 (0.44–1.08)
Unemployed/ot her 57 (44.9) 70 (55.1) 0.75 (0.43–1.31)
Marital status
Single 95 (46.6) 109 (53.4) 0.21 Ref
Married 331 (51.6) 311 (48.4) 0.89 (0.62–1.27)
*

Bold signifies statistically significant associations at p<0.05

**

Age excluded due to collinearity within the limited life expectancies cohort